Insiders who bought US$1.6m worth of RVL Pharmaceuticals plc ( NASDAQ:RVLP ) stock in the last year have seen some of...
-- Expects fourth quarter 2022 preliminary UPNEEQ net product sales of approximately $12.1 million, representing an increase of 21% over the third quarter 2022, and approximately $36.5 million for full year 2022 -- -- Approximately 4,300 cumulative unique medical aesthetics practices had placed orders for UPNEEQ through the end of the fourth quarter 2022, a 23% increase from the end of the third quarter 2022 -- BRIDGEWATER, N.J., Jan. 09, 2023 (GLOBE NEWSWIRE) -- RVL Pharmaceuticals plc (Nasdaq:
RVL Pharmaceuticals plc ( NASDAQ:RVLP ) is possibly approaching a major achievement in its business, so we would like...